Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment

• المؤلفون الرئيسيون: Vineela Parvathaneni (مؤلف), Nishant S. Kulkarni (مؤلف), Snehal K. Shukla (مؤلف), Pamela T. Farrales (مؤلف), Nitesh K. Kunda (مؤلف), Aaron Muth (مؤلف), Vivek Gupta (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2020-02-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Non-small cell lung cancer (NSCLC) is a global disorder, treatment options for which remain limited with resistance development by cancer cells and off-target events being major roadblocks for current therapies. The discovery of new drug molecules remains time-consuming, expensive, and prone to fail...